#USA #Pleasanton #Unchained Labs #Stuntman Automation #AI Developability

Unchained Labs Unveils Game-Changing AI Developability Workcell

On September 8, 2026, Unchained Labs, a forefront player in the life sciences sector, introduced an innovative product known as the AI Developability Workcell. This new system is designed to streamline the research process by integrating advanced automation, sample preparation, unique analytics, and native artificial intelligence, specifically targeting the complex field of biologics.

As researchers in the field of biologics often face the tedious task of developability screening, the traditional methods can become a chaotic juggling act. Samples need to be meticulously prepared, transferred between multiple analytical tools, and each step comes with the additional burden of manually compiling data from various software platforms. This cumbersome process can lead to researchers wasting time and resources on candidates that may not be viable.

The AI Developability Workcell aims to change this narrative by combining several powerful tools on its core platform, Stuntman. By utilizing a trio of specialized components—Stunner, Aunty, and Lil' Tuna—the Workcell enables rapid and efficient screening of biologic candidates all in one unified space. The Stunner component measures essential parameters such as concentration and the size of samples, while Aunty evaluates thermal and colloidal stability. The Lil' Tuna is responsible for critical tasks including buffer exchange and concentration adjustments. This cohesive system allows researchers to screen a larger number of candidates while using significantly less sample material.

The brilliance of the Workcell lies in its ability to maintain connectivity between experiments and data. By leveraging native AI technology, researchers can instantly synthesize results from various tests, processing them without wading through disjointed software systems. This streamlined approach not only simplifies the researcher’s workflow but also enhances decision-making, enabling scientists to rapidly identify and focus on the most promising candidates without the usual chaos.

Tim Harkness, the Founder and CEO of Unchained Labs, articulated the paradigm shift brought about by this new tool, stating, "Developability research has been stuck in the past—samples moving from tool to tool, data trapped in different software, and scientists left to piece together the answer. The AI Developability Workcell changes all of that. Automation, sample prep, analytics, and AI work together from day one—so teams can ditch the chaos, stop chasing data, and start advancing the right candidates in days instead of weeks."

Unchained Labs is committed to empowering researchers by providing them with the precise tools they need to succeed. An ethos of breaking free from outdated methodologies drives their innovation, particularly in the field of biologics, which has seen increasing demand for automation and integrated solutions. The AI Developability Workcell embodies this vision, setting a new standard in the biopharmaceutical industry.

This cutting-edge technology reflects Unchained's dedication to enhancing lab environments through intelligent, AI-driven automation and purpose-built analytical capabilities. Based in Pleasanton, California, Unchained Labs continues to push the boundaries of scientific advancement, ensuring that researchers are equipped with the best tools to achieve their goals.

To learn more about Unchained Labs and their groundbreaking developments, visit www.unchainedlabs.com.